Schizophrénie et COVID : Étude clinique
| dc.contributor.advisor | F. MANOUDI | |
| dc.contributor.author | Amine BOUGHMI | |
| dc.date.accessioned | 2023-09-19T14:15:20Z | |
| dc.date.accessioned | 2026-01-28T12:20:30Z | |
| dc.date.available | 2023-09-19T14:15:20Z | |
| dc.date.issued | 2022 | |
| dc.description.collaborator | I. RAMMOUZ | |
| dc.description.collaborator | K. MOUHADI | |
| dc.description.collaborator | M. A. LAFFINTI | |
| dc.identifier.uri | https://toubkalpreprod.imist.ma/handle/123456789/22011 | |
| dc.language.iso | fr | |
| dc.publisher | Faculté de Médecine et de Pharmacie, Marrakech | fr_FR |
| dc.publisher | Sciences médicales | fr_FR |
| dc.subject.other | Psychiatry | |
| dc.subject.specific | Schizophrénie | |
| dc.subject.specific | Pandémie COVID-19 | |
| dc.subject.specific | Etat mental | |
| dc.subject.specific | Suivi | |
| dc.subject.specific | Scores | |
| dc.subject.specific | Rechutes | |
| dc.title | Schizophrénie et COVID : Étude clinique | fr_FR |
Files
Original bundle
1 - 1 of 1